Literature DB >> 19138107

Pre-differentiated embryonic stem cells promote neuronal regeneration by cross-coupling of BDNF and IL-6 signaling pathways in the host tissue.

Margarita Glazova1, Elena S Pak, Justin Moretto, Sarah Hollis, Kori L Brewer, Alexander K Murashov.   

Abstract

The mechanism of embryonic stem (ES) cell therapeutic action remains far from being elucidated. Our recent report has shown that transplantation of ES cells, predifferentiated into neuronal progenitors, prevented appearance of chronic pain behaviors in mice after experimentally induced spinal cord injury. In the current study, we tested the hypothesis that this beneficial effect is mediated by antiapoptotic and regenerative signaling pathways activated in the host tissue by transplanted ES cells. Spinal cord injury was induced by unilateral microinjections of quisqualic acid at spinal levels T12-L2. At 1 week after injury, the pre-differentiated towards neuronal phenotype ES cells were transplanted into the site of injury. Here we show that transplantation of pre-differentiated ES cells activate both brain-derived neurotrophic factor (BDNF) and interleukin-6 (IL-6) signaling pathways in the host tissue, leading to activation of cAMP/PKA, phosporylation of cofilin and synapsin I, and promoting regenerative growth and neuronal survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138107     DOI: 10.1089/neu.2008.0785

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

Review 1.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 2.  Progress and prospects in neurorehabilitation: clinical applications of stem cells and brain-computer interface for spinal cord lesions.

Authors:  Mariana Gongora; Caroline Peressutti; Sergio Machado; Silmar Teixeira; Bruna Velasques; Pedro Ribeiro
Journal:  Neurol Sci       Date:  2012-11-17       Impact factor: 3.307

3.  Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Nicola Alessio; Giovanni Di Bernardo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Cell Mol Life Sci       Date:  2009-11-24       Impact factor: 9.261

Review 4.  An update on spinal cord injury research.

Authors:  He-Qi Cao; Er-Dan Dong
Journal:  Neurosci Bull       Date:  2012-11-03       Impact factor: 5.203

Review 5.  Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.

Authors:  Anna Heile; Thomas Brinker
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

6.  Intra-Spinal Bone Marrow Mononuclear Cells Transplantation Inhibits the Expression of Nuclear Factor-κB in Acute Transection Spinal Cord Injury in Rats.

Authors:  Rajiv Prasad Shrestha; Jian Min Qiao; Fu Guo Shen; Krishna Bahadur Bista; Zhong Nan Zhao; Jianhua Yang
Journal:  J Korean Neurosurg Soc       Date:  2014-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.